European Journal of Clinical Pharmacology

Title Publication Date Language Citations
Difficulties swallowing solid oral dosage forms in a general practice population: prevalence, causes, and relationship to dosage forms2012/09/29English166
Inappropriate prescribing: a systematic overview of published assessment tools2013/09/10English164
NAT2 genotype guided regimen reduces isoniazid-induced liver injury and early treatment failure in the 6-month four-drug standard treatment of tuberculosis: A randomized controlled trial for pharmacogenetics-based therapy2012/11/14English161
Under-reporting of adverse drug reactions1998/09/02160
Potentially inappropriate medication in the elderly: a systematic review of validated explicit criteria2018/03/27English160
Perception of risk regarding the use of medications and other exposures during pregnancy2009/10/20English159
Agranulocytosis and other blood dyscrasias associated with dipyrone (metamizole)2002/06/06English158
Polypharmacy: correlations with sex, age and drug regimen1998/06/04156
Polymorphisms of drug-metabolizing enzymes CYP2C9, CYP2C19, CYP2D6, CYP1A1, NAT2 and of P-glycoprotein in a Russian population2003/08/01155
The role of population PK–PD modelling in paediatric clinical research2010/03/26English155
Evidence of clinical efficacy of homeopathy2000/04/26154
Identification of human cytochrome P 450 s that metabolise anti-parasitic drugs and predictions of in vivo drug hepatic clearance from in vitro data2003/09/01154
The clinical implications of ageing for rational drug therapy2008/01/05English153
Pharmacokinetics, pharmacodynamics, tolerability and safety of single ascending doses of ticagrelor, a reversibly binding oral P2Y12 receptor antagonist, in healthy subjects2010/01/21English150
High prevalence of the CYP2B6 516G→T(*6) variant and effect on the population pharmacokinetics of efavirenz in HIV/AIDS outpatients in Zimbabwe2007/12/05English146
Pharmacovigilance: methods, recent developments and future perspectives2008/06/04English145
Codeine and morphine in extensive and poor metabolizers of sparteine: pharmacokinetics, analgesic effect and side effects1996/12/12145
Women encounter ADRs more often than do men2008/07/05English144
Contribution of age, body weight, and CYP2C9 and VKORC1 genotype to the anticoagulant response to warfarin: proposal for a new dosing regimen in Chinese patients2007/09/27English142
Delivery outcome after the use of antidepressants in early pregnancy1999/09/09142
Influence of CYP2C9 genotype on warfarin dose requirements—a systematic review and meta-analysis2008/11/25English141
Medication prescribing in frail older people2012/09/11English137
Absolute bioavailability and pharmacokinetics of valsartan, an angiotensin II receptor antagonist, in man1997/04/29136
Prevalence of polypharmacy in a Scottish primary care population2014/02/01English134
Narrow therapeutic index drugs: a clinical pharmacological consideration to flecainide2015/04/15English134
Bioavailability of dexmedetomidine after intranasal administration2011/02/12English133
Influence of beta-blockers on melatonin release1999/04/13133
Prevalence and patterns of antidepressant drug use during pregnancy2006/08/08English129
National campaigns to improve antibiotic use2006/03/28English129
Organising evidence on QT prolongation and occurrence of Torsades de Pointes with non-antiarrhythmic drugs: a call for consensus2001/06/01128